ALK Abello
Annual General Meeting in ALK-Abelló A/S on 13 March 2025
Annual General Meeting in ALK-Abelló A/S on 13 March 2025
ALK (ALKB:DC / OMX: ALK B / AKBLF): The Annual General Meeting of ALK-Abelló A/S will take place on Thursday, 13 March 2025 at 4:00 PM (CET) at ALK-Abelló A/S, Bøge Allé 1, 2970 Hørsholm, Denmark. The agenda of the meeting including the complete proposals from the Board of Directors to the AGM is attached.
ALK-Abelló A/S
For further information please contact:
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Media: Maiken Riise Andersen, tel. +45 5054 1434
About ALK
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,800 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Sportradar AG24.4.2025 06:03:02 CEST | Press release
Sportradar Announces Pricing of Public Offering of Class A Ordinary Shares by Selling Shareholders and Concurrent Share Repurchase
Leading Edge Materials Corp.24.4.2025 00:00:00 CEST | Press release
Leading Edge Materials Announces Results of Annual General Meeting of Shareholders
Galapagos NV23.4.2025 22:01:00 CEST | Press release
Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts
Danske Andelskassers Bank23.4.2025 20:27:46 CEST | Pressemeddelelse
Forløb af generalforsamling i Danske Andelskassers Bank A/S
SBM Offshore Amsterdam B.V.23.4.2025 19:40:31 CEST | Press release
SBM Offshore starts EUR141 million share repurchase following successful completion of the 2024 program
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom